Merck Sued by Sovereign Fund and Other Investors

Merck & Co., the second biggest U.S. pharmaceutical company, is being sued by a number of large institutional investors who opted out of a class-action securities lawsuit certified by a judge in January 2013. By opting out of the class action, these institutional investors are pursuing their own claims. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]


Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute
 
institutional investor investment mandates